526953 Share Price Performance
₹471.10
154.00 (48.57%)
Price ₹471.10
Share Price₹471.10
Venus Remedies Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
526953 Community Narratives
There are no narratives available yet.
Recent 526953 News & Updates
Venus Remedies Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 40.17
- Gross Margin
- 40.91%
- Net Profit Margin
- 8.00%
- Debt/Equity Ratio
- 0.3%
Venus Remedies Limited Competitors
Snowflake Analysis
About 526953
- Founded
- 1989
- Employees
- 1298
- CEO
- WebsiteView website
Venus Remedies Limited engages in the pharmaceutical business in India and internationally. It is involved in the research and development of solutions focusing on antimicrobial resistance and oncology. The company also offers analgesic, analgesic and antipyretic, antibiotic, anticoagulant, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones (steroid), immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, and solvent products, as well as herbal medicine. The company was incorporated in 1989 and is headquartered in Panchkula, India.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Indian Market Performance
- 7 Days: 1.5%
- 3 Months: -1.7%
- 1 Year: -4.7%
- Year to Date: 0.7%
The market is up 1.5% over the last week, with the Financials sector leading the way, up 2.3%. Longer term the market is actually down 4.7% over the past year. Earnings are forecast to grow by 16% annually. Market details ›